首页    期刊浏览 2024年11月30日 星期六
登录注册

文章基本信息

  • 标题:SCP-2/SCP-x gene ablation alters lipid raft domains in primary cultured mouse hepatocytes
  • 本地全文:下载
  • 作者:Atshaves, Barbara P. ; McIntosh, Avery L. ; Payne, H. Ross
  • 期刊名称:JLR Papers In Press
  • 印刷版ISSN:0022-2275
  • 电子版ISSN:1539-7262
  • 出版年度:2007
  • 卷号:48
  • 期号:10
  • 页码:2193-2211
  • DOI:10.1194/jlr.M700102-JLR200
  • 出版社:American Society for Biochemistry and Molecular Biology
  • 摘要:Although reverse cholesterol transport from peripheral cell types is mediated through plasma membrane microdomains termed lipid rafts, almost nothing is known regarding the existence, protein/lipid composition, or structure of these putative domains in liver hepatocytes, cells responsible for the net removal of cholesterol from the body. Lipid rafts purified from hepatocyte plasma membranes by a nondetergent affinity chromatography method were: i) present at 33 ± 3% of total plasma membrane protein; ii) enriched in key proteins of the reverse cholesterol pathway [scavenger receptor class B type I (SR-B1), ABCA1, P-glycoprotein (P-gp), sterol carrier protein-2 (SCP-2)]; iii) devoid of caveolin-1; iv) enriched in cholesterol, sphingomyelin, GM1, and phospholipids low in polyunsaturated fatty acid and double bond index; and v) exhibited an intermediate liquid-ordered lipid phase with significant transbilayer fluidity gradient. Ablation of the gene encoding SCP-2 significantly altered lipid rafts to: i) increase the proportion of lipid rafts present, thereby increasing raft total content of ABCA1, P-gp, and SR-B1; ii) increase total phospholipids while decreasing GM1 in lipid rafts; iii) decrease the fluidity of lipid rafts, consistent with the increased intermediate liquid-ordered phase; and iv) abolish the lipid raft transbilayer fluidity gradient. Thus, despite the absence of caveolin-1 in liver hepatocytes, lipid rafts represented nearly one-third of the mouse hepatocyte plasma membrane proteins and displayed unique protein, lipid, and biophysical properties that were differentially regulated by SCP-2 expression. Supplementary key words sterol carrier protein • SR-B1 • reverse cholesterol transport • ABCA1 Abbreviations: apoA-I, apolipoprotein A-I; cis-parinaric acid, 9Z,11E,13E,15Z-octatetradecanoic acid; ConA, concanavalin A; DBI, double bond index; DHE, dehydroergosterol; DPH, 1,6-diphenyl-1,3,5-hexatriene; DPH-Pro, 3(1,6-diphenyl-1,3,5-hexatrienyl)-propionic acid; DPH-TMA, 1,6-diphyenyl-1,3,5-hexatrienyl-trimethylammonium; eNOS, endothelial nitic oxide synthase; L-FABP, liver fatty acid binding protein; NBD-stearic acid, 12-(N-methyl)-N-[(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-octadecanoic acid; PA, phosphatidic acid; PC, choline glycerophospholipid; PE, ethanolamine glycerophospholipid; P-gp, P-glycoprotein; PI, phosphatidylinositol; PS, phosphatidylserine; RCT, reverse cholesterol transport; SCP-2, sterol carrier protein-2; SM, sphingomyelin; SR-B1, scavenger receptor class B type I
国家哲学社会科学文献中心版权所有